Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146000 | SCV000193149 | benign | not specified | 2013-08-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000146000 | SCV000302651 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000315169 | SCV000414210 | benign | Neuroferritinopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000369896 | SCV000414211 | benign | Hereditary hyperferritinemia with congenital cataracts | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000370536 | SCV000483740 | benign | Glycogen storage disease due to muscle and heart glycogen synthase deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000839535 | SCV000981436 | benign | not provided | 2018-03-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Mendelics | RCV000369896 | SCV001141117 | benign | Hereditary hyperferritinemia with congenital cataracts | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001516688 | SCV001725001 | benign | Hereditary hyperferritinemia with congenital cataracts; Neuroferritinopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000369896 | SCV001933662 | benign | Hereditary hyperferritinemia with congenital cataracts | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701526 | SCV001933664 | benign | L-ferritin deficiency | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000315169 | SCV001933665 | benign | Neuroferritinopathy | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000146000 | SCV005091891 | benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 74% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 69. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000839535 | SCV005306859 | benign | not provided | criteria provided, single submitter | not provided | ||
Tilson |
RCV000144503 | SCV000189822 | likely pathogenic | sporadic abdominal aortic aneurysm | 2014-09-21 | no assertion criteria provided | research | Observed frequency is 15/19 = 0.789 patients with abdominal aortic aneurysm versus heterozygosity is described in "Variation Viewer" as 0.496. |
Diagnostic Laboratory, |
RCV000146000 | SCV001744626 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000146000 | SCV001807191 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000146000 | SCV001954857 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000146000 | SCV001975448 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000146000 | SCV002034272 | benign | not specified | no assertion criteria provided | clinical testing |